Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 3Gynecologic 2Breast 2CNS 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Esophageal Neoplasms 1Breast Neoplasms 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1088Gemcitabine 1046Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 671Radiotherapy 536Cetuximab 470pembrolizumab 430Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 275Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 188Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × ferumoxtran-10 × Gastrointestinal × Clear all
NCT02253602 2019-01-16

IMPROVE

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed
41 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02751606 2018-12-06

Nano MRI on 7 Tesla in Rectal and Breast Cancer

Radboud University Medical Center

Phase 3 Unknown
30 enrolled
BreastGastrointestinal

Breast Neoplasms, Rectal Neoplasms

NCT00920023 2017-07-25

Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)

Massachusetts General Hospital

Phase 4 Completed
35 enrolled 5 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡